[The effect of immunosuppressive therapy on the long acting thyroid stimulator (LATS) and the clinical picture in patients with localized myxedema and exophthalmus].
D002699:Chlorambucil / Q000627:therapeutic use; D006111:Graves Disease / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008135:Long-Acting Thyroid Stimulator / Q000097:blood*; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009230:Myxedema / Q000097:blood / Q000188:drug therapy*
D007166:Immunosuppressive Agents; D002699:Chlorambucil; D008135:Long-Acting Thyroid Stimulator; D015122:Mercaptopurine; D008727:Methotrexate
Der Einfluss von immunosuppressiver Therapie auf den Long-Acting Thyroid Stimulator (LATS) und das klinische Bild bei Patienten mit lokalisiertem Myxödem und Exophthalmus.